GlassScriptPhysician profile
Sreedevi Kodali
NPI 1649498544
$2,199.16
in general payments reported to CMS, 2019-2025
20 companies · $734 in 2025
The $734 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.56 · 2020: $139 · 2021: $41.09 · 2022: $485 · 2023: $374 · 2024: $408 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,516.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $452.41 | 2022-2025 | |
| Galderma Laboratories, L.P. | $374.25 | 2019-2025 | Nemluvio, Oracea, Twyneo |
| Leo Pharma INC. | $182.25 | 2020-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $181.61 | 2023-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $167.53 | 2022-2025 | |
| Amgen INC. | $167.44 | 2022-2025 | Otezla, Otezla |
| Genzyme Corporation | $103.08 | 2022-2025 | |
| Ucb, INC. | $93.43 | 2024-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $73.60 | 2022-2024 | Jublia, Cabtreo |
| E.R. Squibb & Sons, L.L.C. | $55.50 | 2023-2025 | Sotyktu |
| Janssen Biotech, INC. | $50.39 | 2025 | Tremfya, Simponi, Stelara |
| Pfizer INC. | $47.98 | 2022-2025 | |
| Organon LLC | $45.39 | 2025 | Vtama |
| Revance Therapeutics, INC. | $42.30 | 2025 | Daxxify |
| Arcutis Biotherapeutics, INC. | $40.53 | 2025 | Zoryve |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $31.08 | 2023 | Olumiant, Taltz |
| Botanix Sb INC | $29.44 | 2025 | Sofdra |
| Sun Pharmaceutical Industries INC. | $23.60 | 2025 | |
| Dermavant Sciences, INC. | $19.67 | 2024 | Vtama |
| Journey Medical Corporation | $17.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sreedevi Kodali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.